Skip to content

Atazanavir Impurity 19

Atazanavir Impurity 19

Product Description
CAT No.
ALN-A009051
CAS No.
NA
Mol. F.
C44H63N7O8
Mol. Wt.
818
Stock
Please Inquire
Chemical Name : 11-benzyl-5,14-di-tert-butyl-3,6,13,16-tetraoxo-8-(4-(pyridin-2-yl)benzyl)-2,17-dioxa-4,7,8,12,15-pentaazaoctadecan-10-yl 2-amino-3,3-dimethylbutanoate
Smiles : O=C(C(C(C)(C)C)NC(OC)=O)NN(CC(OC(C(C(C)(C)C)N)=O)C(CC1=CC=CC=C1)NC(C(C(C)(C)C)NC(OC)=O)=O)CC2=CC=C(C3=NC=CC=C3)C=C2
Inchi : InChI=1S/C55H42N8O13/c1-3-69-51-56-41-17-9-15-39(45(41)62(51)27-31-19-23-33(24-20-31)35-11-5-7-13-37(35)47-58-53(66)75-60-47)49(64)71-29-43-44(74-55(68)73-43)30-72-50(65)40-16-10-18-42-46(40)63(52(57-42)70-4-2)28-32-21-25-34(26-22-32)36-12-6-8-14-38(36)48-59-54(67)76-61-48/h5-26H,3-4,27-30H2,1-2H3,(H,58,60,66)(H,59,61,67)

Determination of Genotoxic impurity in Atazanavir sulphate drug substance by LC-MS

K. Geetha Bhavania , K. Bala Murali Krishnac , N. Srinivasub* , D. Ramachandranc* , N.V.V.S.S. Ramand , B. Hari Babuc*nJ Pharm Biomed Anal. 2017 Jan 5;132:156-158

Impact of monomeric vs. micellar surfactant and surfactant-polymer interactions on nucleation-induction times of atazanavir from supersaturated solutions

, D. Ramachandranc

Simultaneous Determination of Impurities of Atazanavir and Ritonavir in Tablet Dosage Form by Using Reversed-Phase Ultra Performance Liquid Chromatographic Method

, N.V.V.S.S. Ramand , B. Hari Babuc

Request For Quotation